Urena-Torres P - Search Results

1

Pharmacologic role of vitamin D natural products.

Urena-Torres P, Souberbielle JC. Urena-Torres P, et al. Curr Vasc Pharmacol. 2014 Mar;12(2):278-85. doi: 10.2174/15701611113119990020. Curr Vasc Pharmacol. 2014. PMID: 23713872 Review.

2

Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation.

Ureña Torres PA, Souberbielle JC, Solal MC. Ureña Torres PA, et al. Metabolites. 2022 Mar 20;12(3):266. doi: 10.3390/metabo12030266. Metabolites. 2022. PMID: 35323709 Free PMC article. Review.

3

[Native vitamin D in dialysis patients].

Delanaye P, Bouquegneau A, Krzesinski JM, Cavalier É, Jean G, Urena-Torres P, Souberbielle JC. Delanaye P, et al. Nephrol Ther. 2015 Feb;11(1):5-15. doi: 10.1016/j.nephro.2014.10.004. Epub 2015 Jan 14. Nephrol Ther. 2015. PMID: 25597001 Review. French.

4

[Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease].

Ureña-Torres PA, Cozzolino M, Bover J. Ureña-Torres PA, et al. Nephrol Ther. 2018 Jun;14(4):189-200. doi: 10.1016/j.nephro.2017.03.003. Epub 2018 Mar 12. Nephrol Ther. 2018. PMID: 29545131 Review. French.

5

Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.

Ureña-Torres P, Bridges I, Christiano C, Cournoyer SH, Cooper K, Farouk M, Kopyt NP, Rodriguez M, Zehnder D, Covic A. Ureña-Torres P, et al. Nephrol Dial Transplant. 2013 May;28(5):1241-54. doi: 10.1093/ndt/gfs568. Epub 2013 Jan 16. Nephrol Dial Transplant. 2013. PMID: 23328710 Clinical Trial.

6

Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Houillier P, Stengel B; NephroTest Study Group. Ureña-Torres P, et al. Am J Kidney Dis. 2011 Oct;58(4):544-53. doi: 10.1053/j.ajkd.2011.04.029. Epub 2011 Jul 31. Am J Kidney Dis. 2011. PMID: 21803465

7

Clinical experience with cinacalcet HCl.

Ureña Torres P. Ureña Torres P. Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V27-33. doi: 10.1093/ndt/gfh1053. Nephrol Dial Transplant. 2004. PMID: 15284357

8

[Strategies aiming to control hyperphosphatemia in chronic kidney disease].

Ureña Torres PA. Ureña Torres PA. Nephrol Ther. 2017 Apr;13 Suppl 1:S95-S101. doi: 10.1016/j.nephro.2017.01.002. Nephrol Ther. 2017. PMID: 28577750 Review. French.

9

Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients.

Ureña Torres PA, Bover J, Cohen-Solal M. Ureña Torres PA, et al. Drugs Today (Barc). 2017 Sep;53(9):489-500. doi: 10.1358/dot.2017.53.9.2711938. Drugs Today (Barc). 2017. PMID: 29238762

10

Magnesium-based interventions for normal kidney function and chronic kidney disease.

Massy ZA, Nistor I, Apetrii M, Brandenburg VM, Bover J, Evenepoel P, Goldsmith D, Mazzaferro S, Urena-Torres P, Vervloet MG, Cozzolino M, Covic A, Era-Edta OB. Massy ZA, et al. Magnes Res. 2016 Apr 1;29(4):126-140. doi: 10.1684/mrh.2016.0412. Magnes Res. 2016. PMID: 28007671 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page